Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Enhancing SARS-Co-V-2 Rapid Testing Acceptance in Latinx Communities

Award Number: U01MD018311
ORGANIZATION: NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 11/01/2022
PERIOD OF PERFORMANCE END DATE: 10/31/2025

Group Awards By:

View Award Description

Enhancing SARS-Co-V-2 Rapid Testing Acceptance in Latinx Communities - This project employs a data-informed approach for implementing preventive interventions designed to advance health equity and ameliorate health disparities among vulnerable populations. Building on the successful Phase I and II projects, we will further tailor the Promotores de Salud COVID-19 evidence-based health promotion intervention to experimentally evaluate a brief behavioral self-affirming implementation intention (SAII) intervention; an approach that is evidence-based for increasing acceptance of health messaging, increasing intentions to change, increasing health promoting behaviors, and decreasing psychological distress. We hypothesize (a) the SAII will increase SARS-CoV-2 rapid testing, testing and vaccine acceptance, and health outcomes through enhancing health promotion messaging, reducing stigma, and affirming self-perceptions; and (b) the SAII will serve as a buffer that moderates (lowers) negative effects of COVID-19-related stressors and discrimination on testing and health outcomes. The key targets of the intervention will be structural social determinants of health (i.e., discrimination and mistrust) as barriers to testing acceptance. Project aims are: (1) To pilot test rapid SARS-CoV-2 test distribution and an English and Spanish version of the SAII intervention. The culturally tailored SAII intervention will be offered in Spanish and English and can be administered orally and does not require English language proficiency or literacy; and (2) conduct a clustered randomized trial (CRT) testing a health equity effectiveness hypothesis. We will use a 2- group × 2-time (pre-post) design to randomly assign 400 participants sampled from Mexican Consulate event attendees to either an SAII + Promotores de Salud condition or to a control condition (the Promotores de Salud intervention only) and test (a) hypothesized main effects of the intervention on testing and vaccine acceptance and health outcomes, and (b) hypothesized buffering effects of COVID-19 stressors and discrimination on testing and health outcomes. Linear and generalizable multilevel structural equation modeling will be specified for evaluation. The study design is powered to detect moderate main effects (ES = .30) and moderating effects of the SAII intervention.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$27 )
2026	2023	UNIVERSITY OF OREGON	1776 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	000	1	3/2/2026	NEW	-$27
														Subtotal = -$27

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2023	UNIVERSITY OF OREGON	1776 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	001	1	9/12/2024	NEW	$0
2024	2023	UNIVERSITY OF OREGON	1776 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	002	1	9/12/2024	SUPPLEMENT FOR EXPANSION	$0
2024	2023	UNIVERSITY OF OREGON	1585 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	000	1	10/31/2023	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $1,024,652 )
2023	2023	UNIVERSITY OF OREGON	1585 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	003	1	5/23/2023	SUPPLEMENT FOR EXPANSION	$508,458
2023	2023	UNIVERSITY OF OREGON	1585 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	001	1	5/16/2023	NEW	$0
2023	2023	UNIVERSITY OF OREGON	1585 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	002	1	5/23/2023	NEW	$0
2023	2023	UNIVERSITY OF OREGON	1585 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	004	1	8/27/2023	NEW	$0
2023	2023	UNIVERSITY OF OREGON	1585 E 13TH AVE	EUGENE	OR	97403	LANE	USA	Trans-NIH Research Support	000	1	10/31/2022	NEW	$516,194
														Subtotal = $1,024,652

Grand Total All Awards = $1,024,625

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Enhancing SARS-Co-V-2 Rapid Testing Acceptance in Latinx Communities

Award Number: U01MD018311

ORGANIZATION: NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 11/01/2022

PERIOD OF PERFORMANCE END DATE: 10/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer